The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Explore this paper's citation graph
Summary
To determine the characteristics of HCV-infected persons in the general United States population today and to monitor trends in prevalence, data on HCV infection from the most recent NHANES was analyzed.
- Type
- article
- Published
- 2006-05-16
- Cited by
- 2,000
- References
- 34
- Access
- Open access
- OpenAlex
- https://openalex.org/W2111044696
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7293614
Keywords
Medicine, Hepatitis C virus, Hepatitis C, National Health and Nutrition Examination Survey, Population
References
- Estimating future hepatitis C morbidity, mortality, and costs in the United States.
- Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.
- Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion
- The declining risk of post-transfusion hepatitis C virus infection.
- Risk factors for hepatitis C virus infection in United States blood donors
- Viral Hepatitis and Other Infectious Diseases in a Homeless Population
- Projecting future complications of chronic hepatitis C in the United States
- Hepatitis C incidence—a comparison between injection and noninjection drug users in New York City
- Diagnosis, management, and treatment of hepatitis C
- The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades
- Hepatitis C epidemiology: Injecting new tools in the field
- Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
- Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti‐HCV
- The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
- Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for Infection
- Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
- Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.
- Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.
- Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.
Cited by
- I linfociti T regolatori nella patologia epatica da HCV: dall'epatite cronica al trapianto
- Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy
- Changing Trends in Viral Hepatitis-Associated Hospitalizations in the American Indian/Alaska Native Population, 1995–2007
- Managing chronic hepatitis C in the difficult-to-treat patient
- Liver Transplantation in the Ethnic Minority Population: Challenges and Prospects
- Benefits of Retention in Methadone Maintenance and Chronic Medical Conditions as Risk Factors for Premature Death Among Older Heroin Addicts
- Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels
- A patient with a leg rash, pedal edema, renal failure, and thrombocytopenia.
- Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C
- Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
- Perspective: Test and treat this silent killer
- Economic burden associated with patients diagnosed with hepatitis C.
- Prevalence of HCV Risk Behaviors Among Prison Inmates: Tattooing and Injection Drug Use
- Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.
- Global burden of hepatitis C: considerations for healthcare providers in the United States.
- Predictors of Active Injection Drug Use in a Cohort of Patients Infected With Hepatitis C Virus
- Public health issues of hepatitis C virus infection.
- Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.
- A nationwide seroepidemiology of hepatitis C virus infection in South Korea
- A Unique Model for Treating Chronic Hepatitis C in Patients With Psychiatric Disorders, Substance Abuse, and/or Housing Instability
Related papers
- Changes in Patientsʼ Knowledge and Perception of Hepatitis C Infection in the United States: Data from the National Health and Nutrition Examination Survey (NHANES): 361
- Cigarette smoking in persons living with hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999–2014
- Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
- Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
- Treatment of hepatitis C virus in the coinfected patient.
- New therapies for hepatitis C virus infection.
- Direct antiviral agents (DAAs) ‐ A new age in the treatment of hepatitis C virus infection
- Evidence for involvement of MHC restrictive mechanisms in hepatitis C virus (HCV) infection and HCV associated liver disease in renal transplant patients
- The detection of hepatitis C virus in South Hungary.
- Survival after liver transplantation for hepatocellular carcinoma in the model for end‐stage liver disease and pre–model for end‐stage liver disease eras and the independent impact of hepatitis C virus